Buradasınız

Anasayfa » Content

A descriptive study of Polycystic ovarian syndrome in adolescent girls among a tertiary care hospital of Bangalore

Journal Name:

  • Indian Journal of Basic & Applied Medical Research

Publication Year:

  • 2015

Key Words:

Author Name
Abstract (2. Language): 
Background: Polycystic ovarian syndrome (PCOS) is one of the most common reproductive endocrinological disorders with a broad spectrum of clinical manifestations affecting about 6-8% of women of reproductive years. Objectives: To determine the prevalence of PCOS among adolescent girls attending Gynaecology OPD of a tertiary care hospital. Materials and Methods: Present study is a descriptive study conducted in Gynaecology OPD of Dr.B. R Ambedkar Medical College, Bangalore.Study population comprised of Adolescent girls attending the gynaecology OPD were included in the study. Data thus obtained was entered in MS excel and data was analysed using SPSS version 17. Appropriate statistical tests were applied and p value of < 0.05 was considered as significant. Results: A total of 126 adolescent girls had visited the Gynaecology OPD from Jully – August 2014 . Majority that is 76.2% of adolescents were in their late adolescence. Ultrasound report of the adolescents revealed that 30(23.8%) of them were diagnosed as PCOS . This difference was statistically significant. Conclusion: Early diagnosis and intervention will reduce the long term health complications associated with PCOS.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-descriptive-study-polycystic-ovarian-syndrome-adolescent-girls-among-tertiary-care-hospital-bangalore.pdf
  • 2
453
457
  • English

REFERENCES

References: 

1. Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the
polycystic ovary syndrome during the reproductive life span. J ClinEndocrinolMetab 2005;90:4650-8.
2. Eshre R. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic
ovary syndrome. Fertility and Sterility 2004;81(1):19.
3. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene,
metformin, or both for infertility in the polycystic ovary syndrome. New England Journal of Medicine
2007;356(6):551–66.
4. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability
(YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global
Burden of Disease Study 2010. Lancet 2012;380(9859):2163-96.
5. Bohler H Jr, Mokshagundam S, Winters SJ. Adipose tissue and reproduction in women. FertilSteril
2010;94(3): 795-825.
6. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al; American Heart
Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic
syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific
Statement. Circulation 2005;112(17):2735-52
7. Farrell K, Antoni MH. Insulin resistance, obesity, inflammation, and depression in polycystic ovary
syndrome: biobehavioral mechanisms and interventions. FertilSteril 2010;94(5):1565-74.
8. Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP. Polycystic ovary syndrome is
associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J
ClinEndocrinolMetab 2001;86(2):517-20.
9. Tasali E, Van Cauter E, Ehrmann DA. Relationships between sleep disordered breathing and glucose
metabolism in polycystic ovary syndrome. J ClinEndocrinolMetab 2006;91(1):36-42.
10. Cerda C, Pérez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, et al. Nonalcoholic
fatty liver disease in women with polycystic ovary syndrome. J Hepatol 2007;47(3):412-7.
11. Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet
2003;361(9371):1810-2.
12. Giudice LC. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Pract Res
ClinEndocrinolMetab 2006;20(2):235-44.
456
Indian Journal of Basic and Applied Medical Research; March 2015: Vol.-4, Issue- 2, P. 453-457
454
www.ijbamr.com P ISSN: 2250-284X , E ISSN : 2250-2858
13. Patel SM, Nestler JE. Fertility in polycystic ovary syndrome. EndocrinolMetabClin North Am
2006;35(1):137-55, vii.
14. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary
syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
FertilSteril 2009;92(6):1966-82.
15. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al;
Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS
Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the
complete task force report. FertilSteril 2009;91(2):456-88.
16. Gainie MA, Khurana ML, Eunice M, Gupta N, Diwivedi SN, Gulati MS, et al. Prevalence of glucose
intolerance among adolescent and young women with polycystic ovary syndrome in India. Indian J
EndocrinolMetab 2004.
17. Williamson K, Gunn AJ, Johnson N, Milsom SR. The impact of ethnicity on the presentation of
polycystic ovarian syndrome. Aust N Z J ObstetGynaecol 2001;41(2):202-6.
18. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in
Indian adolescents. J PediatrAdolescGynecol 2011;24(4):223-7.
19. Shaista Salman Guraya, Prevalence and ultrasound features of Polycystic ovaries in young unmarried
Saudi females, Jounal of Microscopy and Ultrastructure:1(2013) 30-34 .
20. Kumarapeli V, Seneviratne R de A, Wijeyaratne CN, Yapa RM., Dodampahala SH. A simple screening
approach for assessing community prevalence and phenotypes of polycystic ovary syndrome in
semiurban population in Srilanka. Am J Epidemiol 2008;168:321-7.

Thank you for copying data from http://www.arastirmax.com